APA (7th ed.) Citation

Sadaga, Y., Watanabe, D., Najima, Y., Sadato, D., Hirama, C., Kato, K., . . . Mizuchi, D. (2025). Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation. Hematology, 30(1), 1. https://doi.org/10.1080/16078454.2025.2539550

Chicago Style (17th ed.) Citation

Sadaga, Yasutaka, et al. "Ponatinib/blinatumomab for Relapsed Philadelphia Chromosome-positive Leukemia as a Bridge to Allogeneic Transplantation." Hematology 30, no. 1 (2025): 1. https://doi.org/10.1080/16078454.2025.2539550.

MLA (9th ed.) Citation

Sadaga, Yasutaka, et al. "Ponatinib/blinatumomab for Relapsed Philadelphia Chromosome-positive Leukemia as a Bridge to Allogeneic Transplantation." Hematology, vol. 30, no. 1, 2025, p. 1, https://doi.org/10.1080/16078454.2025.2539550.